Fulvestrant Injection

Fulvestrant Injection

Categories : Oncology

Product Packaging : PFS

Product Composition : 250mg/5ml (PFS)

Fulvestrant Injection is a specialized hormonal anticancer (endocrine therapy) injectable formulation used primarily in the treatment of hormone receptor-positive (HR+) metastatic breast cancer in postmenopausal women. Fulvestrant is a selective estrogen receptor degrader (SERD) that works by binding to estrogen receptors and promoting their degradation, thereby blocking estrogen-driven tumor growth.

This oncology injectable is widely used in advanced breast cancer therapy, either as monotherapy or in combination with targeted agents. The injectable formulation ensures controlled drug delivery and sustained therapeutic effect, making it an essential option in hormone-dependent cancer management.

Manufactured under stringent sterile and oncology-grade conditions, Fulvestrant Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent efficacy. As a trusted Fulvestrant Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label injectable solutions, and global bulk supply.

Send Message

Fulvestrant Injection is a specialized hormonal anticancer (endocrine therapy) injectable formulation used primarily in the treatment of hormone receptor-positive (HR+) metastatic breast cancer in postmenopausal women. Fulvestrant is a selective estrogen receptor degrader (SERD) that works by binding to estrogen receptors and promoting their degradation, thereby blocking estrogen-driven tumor growth.

This oncology injectable is widely used in advanced breast cancer therapy, either as monotherapy or in combination with targeted agents. The injectable formulation ensures controlled drug delivery and sustained therapeutic effect, making it an essential option in hormone-dependent cancer management.

Manufactured under stringent sterile and oncology-grade conditions, Fulvestrant Injection offered by Genliva Wellness LLP ensures high purity, safety, and consistent efficacy. As a trusted Fulvestrant Injection contract manufacturer and exporter from India, Genliva Wellness LLP provides oncology-focused third-party manufacturing, private label injectable solutions, and global bulk supply.

Fulvestrant Injection is commonly used in the treatment of:

  • Hormone receptor-positive (HR+) metastatic breast cancer
  • Advanced breast cancer in postmenopausal women
  • Disease progression after anti-estrogen therapy
  • Used in combination with targeted therapies (as per protocols)

This hormonal anticancer injection is administered under strict medical supervision in oncology settings.

Injectable dosage form offers key advantages in endocrine oncology therapy:

  • Long-acting and controlled drug delivery
  • Ensures consistent therapeutic levels
  • Suitable for deep intramuscular administration
  • Improves patient compliance in long-term therapy
  • Ideal for hospital and oncology center use
  • Supports global oncology contract manufacturing and export supply

whatsapp-app